Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Feb;10(1):61-70.
doi: 10.1111/j.1751-2980.2008.00366.x.

Fermented Milk Containing Bifidobacterium Lactis DN-173 010 Improved Self-Reported Digestive Comfort Amongst a General Population of Adults. A Randomized, Open-Label, Controlled, Pilot Study

Affiliations
Randomized Controlled Trial

Fermented Milk Containing Bifidobacterium Lactis DN-173 010 Improved Self-Reported Digestive Comfort Amongst a General Population of Adults. A Randomized, Open-Label, Controlled, Pilot Study

Denis Guyonnet et al. J Dig Dis. .

Abstract

Aim: Some probiotics improve digestive comfort of people with Irritable Bowel Syndrome, but this needs confirmation in a healthy population. The objective of this pilot study was to investigate the effect of consuming fermented milk containing the probiotics Bifidobacterium lactis DN-173010 and yoghourt strains (test product) on digestive comfort and symptoms amongst adults without diagnosed gastrointestinal disorders.

Methods: The study was designed to approximate a real-life situation, by using a branded product in the intervention groups. In an open-label, randomized, controlled trial, 371 adults reporting digestive discomfort were randomized into three groups who had a daily consumption of either one or two pots of test product over 2 weeks, or to follow their usual diet. Digestive comfort and bother from digestive symptoms were assessed by questionnaire at baseline and follow-up (per protocol population n = 360). Self-reported change in digestive comfort and computed change between baseline and follow-up for each of 20 items were compared between groups (Cochran-Mantel-Haenszel test).

Results: A higher percentage of participants consuming the test product reported improved digestive comfort (1-pot group 82.5%; 2-pot group 84.3%), than controls (2.9%). Their self-reported change scores differed significantly (P < 0.001). For both test product groups, almost all symptom scores improved significantly more than controls (P < 0.001). There were no significant differences between 1-pot and 2-pot groups.

Conclusions: This pilot study shows that daily consumption of a probiotic food in real-life conditions may be useful in improving digestive comfort and symptom experience of adults from general population. Further double-blind randomized controlled studies are required to confirm these health benefits.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

Publication types

Substances

LinkOut - more resources

Feedback